Literature DB >> 6306098

Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8).

J Mumford, J M Wood, A M Scott, C Folkers, G C Schild.   

Abstract

Forty ponies immunized with inactivated virus vaccine containing A/equine/Miami/63 (H3N8) virus and six unvaccinated, seronegative ponies were experimentally challenged with a representative of recent equine H3N8 virus isolates, A/equine/Newmarket/79. All unvaccinated ponies became infected as judged by virus excretion, febrile responses and antibody responses, but only two of the vaccinated ponies were fully protected. Pre-challenge antibody levels to A/Newmarket/79 virus detected by single radial haemolysis (SRH) correlated well with the degree of clinical protection but the levels required for complete protection (SRH zones greater than 65 mm2) were high. The importance of these results in relation to conventional vaccination procedures against equine influenza is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6306098      PMCID: PMC2134271          DOI: 10.1017/s0022172400029016

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  23 in total

1.  Cytotoxic T cells in the lungs of mice infected with an influenza A virus.

Authors:  K L Yap; G L Ada
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

2.  Experimental pathogenesis of A-equi 1 influenza virus infection in horses.

Authors:  D Blaskovic; J Szántó; B Kapitáncik; J Lesso; V Lackovic; R Skarda
Journal:  Acta Virol       Date:  1966-11       Impact factor: 1.162

3.  Parainfluenza 2 virus: increase in hemagglutinin titer on treatment with Tween-80 and ether.

Authors:  T J John; V A Fulginiti
Journal:  Proc Soc Exp Biol Med       Date:  1966-01

4.  The response of ponies to Myxovirus influenzae A-Equi-2. 3. The protective effect of serum and nasal antibody against experimental challenge.

Authors:  B T Rouse; W J Ditchfield
Journal:  Res Vet Sci       Date:  1970-11       Impact factor: 2.534

5.  Antibody responses in nasal secretions and serum of elderly persons following local or parenteral administration of inactivated influenza virus vaccine.

Authors:  J A Kasel; E B Hume; R V Fulk; Y Togo; M Huber; R B Hornick
Journal:  J Immunol       Date:  1969-03       Impact factor: 5.422

6.  Equine influenza. Studies of the virus and of antibody patterns in convalescent, interepidemic and postvaccination sera.

Authors:  F S Lief; D Cohen
Journal:  Am J Epidemiol       Date:  1965-11       Impact factor: 4.897

7.  The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection.

Authors:  J S Oxford; G C Schild; C W Potter; R Jennings
Journal:  J Hyg (Lond)       Date:  1979-02

8.  Host defenses against influenza virus: the role of anti-hemagglutinin antibody.

Authors:  J L Virelizier
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

9.  Strain-specificity of antibody to haemagglutinin following inactivated A/port chalmers/1/73 vaccine in man: evidence for a paradoxical strain-specific antibody response.

Authors:  G C Schild; J W Smith; L Cretescu; R W Newman; J M Wood
Journal:  Dev Biol Stand       Date:  1977 Jun 1-3

10.  Field observations on influenza vaccination among horses in Britain, 1971-1976.

Authors:  D G Powell; R Burrows; P Spooner; J Mumford; G Thomson
Journal:  Dev Biol Stand       Date:  1977 Jun 1-3
View more
  13 in total

1.  Characterization of the equine influenza virus H3 with monoclonal antibodies.

Authors:  J A Appleton; D F Antczak; A D Lopes
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

Review 2.  Cross talk between animal and human influenza viruses.

Authors:  Makoto Ozawa; Yoshihiro Kawaoka
Journal:  Annu Rev Anim Biosci       Date:  2013-01-01       Impact factor: 8.923

3.  Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies.

Authors:  Alida Ault; Alyse M Zajac; Wing-Pui Kong; J Patrick Gorres; Michael Royals; Chih-Jen Wei; Saran Bao; Zhi-yong Yang; Stephanie E Reedy; Tracy L Sturgill; Allen E Page; Jennifer Donofrio-Newman; Amanda A Adams; Udeni B R Balasuriya; David W Horohov; Thomas M Chambers; Gary J Nabel; Srinivas S Rao
Journal:  Vaccine       Date:  2012-03-23       Impact factor: 3.641

4.  Protection against experimental infection with influenza virus A/equine/Miami/63 (H3N8) provided by inactivated whole virus vaccines containing homologous virus.

Authors:  J A Mumford; J M Wood; C Folkers; G C Schild
Journal:  Epidemiol Infect       Date:  1988-06       Impact factor: 2.451

5.  Origin of the hemagglutinin on A/Equine/Johannesburg/86 (H3N8): the first known equine influenza outbreak in South Africa.

Authors:  Y Kawaoka; R G Webster
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

6.  Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant.

Authors:  J A Mumford; H Wilson; D Hannant; D M Jessett
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

7.  Control of equine influenza: scenario testing using a realistic metapopulation model of spread.

Authors:  M Baguelin; J R Newton; N Demiris; J Daly; J A Mumford; J L N Wood
Journal:  J R Soc Interface       Date:  2009-04-01       Impact factor: 4.118

8.  Studies with inactivated equine influenza vaccine. 1. Serological responses of ponies to graded doses of vaccine.

Authors:  J M Wood; J Mumford; C Folkers; A M Scott; G C Schild
Journal:  J Hyg (Lond)       Date:  1983-06

9.  Comparison of two modern vaccines and previous influenza infection against challenge with an equine influenza virus from the Australian 2007 outbreak.

Authors:  Neil A Bryant; Romain Paillot; Adam S Rash; Elizabeth Medcalf; Fernando Montesso; Julie Ross; James Watson; Martyn Jeggo; Nicola S Lewis; J Richard Newton; Debra M Elton
Journal:  Vet Res       Date:  2009-10-29       Impact factor: 3.683

10.  The effects of strain heterology on the epidemiology of equine influenza in a vaccinated population.

Authors:  A W Park; J L N Wood; J M Daly; J R Newton; K Glass; W Henley; J A Mumford; B T Grenfell
Journal:  Proc Biol Sci       Date:  2004-08-07       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.